| Balance Sheets | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Property and equipment, net | 72,482 | 62,075 | 39,474 | 35,137 |
| Other assets | 38,541 | 28,582 | 6,401 | 2,339 |
| Total assets | 1,401,182 | 1,271,405 | 1,121,694 | 983,065 |
| Accrued expenses and other current liabilities | 75,147 | 74,810 | 47,767 | 69,489 |
| Total current liabilities | 100,958 | 106,383 | 77,280 | 88,040 |
| Other liabilities | 28,493 | 29,308 | 2,852 | 5,413 |
| Total liabilities | 129,451 | 135,691 | 80,132 | 93,453 |
| Common stock, 0.0001 par value 1,000,000 shares authorized as of september 30, 2025 and december 31, 2024 168,903 and 162,018 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively | 17 | 17 | 16 | 16 |
| Additional paid-in capital | 1,302,261 | 1,258,581 | 1,216,495 | 1,118,675 |
| Accumulated other comprehensive income | 4,097 | 2,874 | 2,028 | 4,430 |
| Accumulated deficit | -34,644 | -125,758 | -176,977 | -233,509 |
| Total stockholders equity | 1,271,731 | 1,135,714 | 1,041,562 | 889,612 |
| Total liabilities and stockholders equity | 1,401,182 | 1,271,405 | 1,121,694 | 983,065 |
Astera Labs, Inc. (ALAB)
Astera Labs, Inc. (ALAB)